Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065213Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of postoperative delirium. Planned start Nov 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065213.